Alps Group Inc(ALPS)

Biotechnology · Kuala Lumpur, WP

$0.38-0.02 (-5.00%)

Delayed quote: Oct 6, 2026, 1:03 PM EDT

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T17:05:37.828Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:05:37.828Z.

Quote observation: 2026-10-06T17:03:25.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 0.38
Unrounded diluted TTM EPS · period ending 2025-09-30: N/A

FMP input reference: 473da95602fdb42a5f780e5c02853506da999e38a33e04168dea7648cb5c925f

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

ALPS PE Ratio Metrics

PE RATIO

N/A

ALPS Competitors' PE Ratio

ALPS

Alps Group Inc

Current

Market Cap

$63.23M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PLRX

Pliant Therapeutics, Inc.

vs ALPS

Market Cap

$63.78M

PE Ratio

N/A

TTM Avg

45.99

3Y Avg

45.99

5Y Avg

45.99

RNXT

RenovoRx, Inc.

vs ALPS

Market Cap

$64.20M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HRTX

Heron Therapeutics, Inc.

vs ALPS

Market Cap

$64.56M

PE Ratio

N/A

TTM Avg

2.96

3Y Avg

2.96

5Y Avg

2.96

CING

Cingulate Inc.

vs ALPS

Market Cap

$65.46M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GOSS

Gossamer Bio, Inc.

vs ALPS

Market Cap

$64.77M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INCR

InterCure Ltd.

vs ALPS

Market Cap

$65.15M

PE Ratio

N/A

TTM Avg

14.25

3Y Avg

33.42

5Y Avg

30.04

KLRS

Kalaris Therapeutics Inc

vs ALPS

Market Cap

$61.12M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACET

Adicet Bio, Inc.

vs ALPS

Market Cap

$60.11M

PE Ratio

N/A

TTM Avg

110.41

3Y Avg

110.41

5Y Avg

110.41

XBIT

XBiotech Inc.

vs ALPS

Market Cap

$65.85M

PE Ratio

N/A

TTM Avg

0.90

3Y Avg

0.90

5Y Avg

0.90

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Alps Group Inc (ALPS)	$63.23M	N/A	N/A	N/A	N/A
Pliant Therapeutics, Inc. (PLRX)vs ›	$63.78M	N/A	45.99	45.99	45.99
RenovoRx, Inc. (RNXT)vs ›	$64.20M	N/A	N/A	N/A	N/A
Heron Therapeutics, Inc. (HRTX)vs ›	$64.56M	N/A	2.96	2.96	2.96
Cingulate Inc. (CING)vs ›	$65.46M	N/A	N/A	N/A	N/A
Gossamer Bio, Inc. (GOSS)vs ›	$64.77M	N/A	N/A	N/A	N/A
InterCure Ltd. (INCR)vs ›	$65.15M	N/A	14.25	33.42	30.04
Kalaris Therapeutics Inc (KLRS)vs ›	$61.12M	N/A	N/A	N/A	N/A
Adicet Bio, Inc. (ACET)vs ›	$60.11M	N/A	110.41	110.41	110.41
XBiotech Inc. (XBIT)vs ›	$65.85M	N/A	0.90	0.90	0.90

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

ALPS PE Ratio Metrics

ALPS Competitors' PE Ratio

P/E Comparison

PE Ratio Formula & Definition

Related Metrics